A team of collaborators, including UK DRI centres in Cambridge and Edinburgh have performed detailed brain cell analysis to uncover new mechanisms thought to underlie Parkinson’s disease.
Read Article
Awarded for work on neurodegenerative or psychiatric diseases, this year's prize goes to Prof David Rubinsztein, UK DRI at University of Cambridge, for his work on autophagy and neurodegeneration.
Read Article
As one of our founding funders, we were proud to feature at this year's annual conference from Alzheimer's Research UK (March 20-21, London).
Read Article
In the first of our six openings this year, our Edinburgh centre set the bar exceptionally high!
Read Article
Almost £400,000 will be invested over the next three years to fund two postdoctoral posts.
Read Article
Under the leadership of the Chair, William Rucker, the Board of Trustees will have collective responsibility for the effective governance and development of the UK DRI, setting its strategic direction and major policies with the Directors and senior UK DRI staff in line with the institute's objectives.
This research represents an early step in our understanding of why motor neurons are highly vulnerable in ALS.
Read Article
This new funding will contribute to an iconic £250m new building at UCL which will host the central hub of UK DRI alongside the university’s world-class Institute of Neurology (IoN).
Read Article
We’re over the moon that UK DRI Director Bart De Strooper and UK DRI Professor John Hardy have been awarded the world’s most valuable prize for brain research.
Read Article
The UK DRI responds to the latest news that Merck is stopping a phase 3 trial in Alzheimer’s disease.
Read Article
The showcase provided the opportunity to raise awareness among parliamentarians and policymakers of the importance of medical research to human health and wellbeing, innovation and economic growth.
Read Article
A new study shows that a loss of synapses in the brain is linked to cognitive decline in ALS.
Read Article
Our Director responds to Pfizer's decision to end their efforts in dementia drug discovery
Read Article
Experts researching the science of sleep join the UK DRI and turn their attention to dementia for the first time.
Read Article
Our researchers from UCL publish the first large-scale genetic study of this common type of dementia.
Read Article
The £1.5m programme will be led by Professors Gillian Bates and Sarah Tabrizi from University College London (UCL) and will look to better understand the DNA damage that occurs as this neurodegenerative disease unfolds.
Read Article
We're seeking an inspirational associate director to lead an ambitious care & technology programme.
Read Article
William will lead the UK DRI Board for the effective governance and development of the UK DRI, setting its strategic direction and major policies.
Read Article
The group in Edinburgh provide insights into how a key chemical disrupts brain cells in Dementia with Lewy Bodies.
Read Article
Professor Bart De Strooper is recognised for his contributions to our understanding of Alzheimer's disease.
Read Article
